Involvement of pulmonary arteriopathy in the development and severity of reperfusion pulmonary edema after pulmonary endarterectomy.
chronic thromboembolic pulmonary hypertension
complication
hypoxia
residual hypertension
Journal
Pulmonary circulation
ISSN: 2045-8932
Titre abrégé: Pulm Circ
Pays: United States
ID NLM: 101557243
Informations de publication
Date de publication:
Historique:
pubmed:
9
4
2019
medline:
9
4
2019
entrez:
9
4
2019
Statut:
ppublish
Résumé
Reperfusion pulmonary edema (RPE) is a common complication after pulmonary endarterectomy (PEA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, the precise mechanisms underlying the development of RPE remain unclear. To evaluate the effects of pulmonary vasculopathy on RPE, the severity of the pulmonary arteriopathies and venopathies of lung tissues biopsied during PEA were pathologically quantified in 33 CTEPH patients. The severity of RPE was classified from grade 0 (no RPE) to 4 (death due to RPE) based on the arterial oxygen tension/inspiratory oxygen fraction (P/F ratio) and necessity of respiratory management. Among the 33 patients (27 women; mean age = 63.3 years), 17 (51.5%) patients developed RPE. The severity of pulmonary arteriopathy (obstruction ratio) correlated with the grade of RPE (r = 0.576, P = 0.0005). The obstruction ratio also correlated with the P/F ratio (r = -0.543, P = 0.001) and the perioperative mean pulmonary arterial pressure (r = 0.445, P = 0.009). Multivariate logistic regression analysis revealed that the obstruction ratio was a significant independent determinant for the development of RPE (odds ratio = 15.7; 95% confidence interval = 2.29-108.00, P = 0.005). In conclusion, pulmonary arteriopathy could be a determinant of the development and severity of RPE after PEA.
Identifiants
pubmed: 30957648
doi: 10.1177/2045894019846439
pmc: PMC6540513
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2045894019846439Références
Eur J Cardiothorac Surg. 1999 Jul;16(1):38-43
pubmed: 10456400
Ann Surg. 2000 Mar;231(3):424-31
pubmed: 10714636
Am J Respir Crit Care Med. 2000 Nov;162(5):1932-9
pubmed: 11069837
AJR Am J Roentgenol. 2002 Nov;179(5):1209-15
pubmed: 12388501
Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4
pubmed: 14602267
Eur J Cardiothorac Surg. 2005 Dec;28(6):882-8
pubmed: 16242948
J Thorac Cardiovasc Surg. 2006 Feb;131(2):307-13
pubmed: 16434258
Circ J. 2008 Jul;72(7):1136-41
pubmed: 18577824
Expert Rev Respir Med. 2011 Apr;5(2):217-29; quiz 230-1
pubmed: 21510732
Chest. 2012 Jan;141(1):27-35
pubmed: 21835900
Eur Respir J. 2013 Mar;41(3):735-42
pubmed: 23143539
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Respir Investig. 2013 Sep;51(3):134-46
pubmed: 23978639
Respiration. 2014;88(2):148-57
pubmed: 24853728
J Thorac Cardiovasc Surg. 2014 Dec;148(6):3014-9
pubmed: 24929804
Eur Respir J. 2014 Nov;44(5):1275-88
pubmed: 25142477
PLoS One. 2015 Aug 07;10(8):e0133167
pubmed: 26252755
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Circulation. 2016 Mar 1;133(9):859-71
pubmed: 26826181
PLoS One. 2016 Aug 29;11(8):e0161827
pubmed: 27571267
Crit Care Med. 2017 Apr;45(4):e409-e417
pubmed: 28145907
Am Rev Respir Dis. 1986 Dec;134(6):1241-5
pubmed: 3789523
Chest. 1993 Mar;103(3):685-92
pubmed: 8449052
Heart. 1997 Aug;78(2):171-6
pubmed: 9326993